Physiomics (GB:PYC) has released an update.
Physiomics PLC’s CEO, Dr. Peter Sargent, has increased his stake in the company by purchasing 459,090 ordinary shares on the London Stock Exchange. This move reflects confidence in the company’s strategic direction and potential for growth in the biotech sector. Physiomics specializes in using advanced data science and modeling to assist pharmaceutical companies in drug development.
For further insights into GB:PYC stock, check out TipRanks’ Stock Analysis page.
